Finance

Beta
Lists
DARE:NASDAQ
Dare Bioscience Inc
US$ २.०६
-०.९६%
(-०.०२०) 1D
जुलाई ७, ११:३३:३१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DARE...
Open
US$ २.०७
High
US$ २.१०
Low
US$ २.०१
Mkt. cap
३.०९ करोड
Avg. vol.
१.८७ लाख
Volume
५७.६२ हजार
52-wk high
US$ ९.१९
52-wk low
US$ १.२७
EPS
-US$ १.०४
Beta
१.०३
Shares outstanding
१.५० करोड
No. of employees
२१
Open
US$ २.०७
High
US$ २.१०
Low
US$ २.०१
Mkt. cap
३.०९ करोड
Avg. vol.
१.८७ लाख
Volume
५७.६२ हजार
52-wk high
US$ ९.१९
52-wk low
US$ १.२७
EPS
-US$ १.०४
Beta
१.०३
Shares outstanding
१.५० करोड
No. of employees
२१
News stories
From sources across the web
24/7 Wall St.
24/7 Wall St.
·
१२ मिनेट पहिले
SpaceX Erases All Post-IPO Gains. Will Today’s Nasdaq-100 Addition Help?
富途牛牛
富途牛牛
·
१९ मिनेट पहिले
Dow Jones Top Energy Headlines at 11 AM ET: Oil Futures Pick Up After Iran Fires At Vessels | Rising ...
Investor's Business Daily
Investor's Business Daily
·
२ घण्टा पहिले
SpaceX Joins Nasdaq 100 Riding A Wave Of Buy Ratings
CNBC
CNBC
·
३ घण्टा पहिले
Trump Accounts, the Dow's latest record, Microsoft layoffs and more in Morning Squawk
About Dare Bioscience Inc
CEOSabrina Martucci Johnson
Employees२१
Founded२००५
Headquartersसान डिएगो, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitedarebioscience.com
Analyst ratings
Based on 2 analysts giving stock ratings to DARE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for DARE in the last 3 months.
Highest
Current US$ २.०६
US$ १२.०० (+४८२.५२%)
Average
US$ १०.०० (+३८५.४४%)
Lowest
US$ ८.०० (+२८८.३५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ८.००
+२८८.३%
05/18/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
US$ १२.००
+४८२.५%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
-२१.१७ हजार
२.२६ हजार
१०.२४ लाख
१.५२ लाख
Cost of goods sold
-
११.७५ लाख
-४६.०६ लाख
९.०३ लाख
Cost of revenue
-
११.७५ लाख
-४६.०६ लाख
९.०३ लाख
Research and development expenses
१४.२९ लाख
-
५५.२३ लाख
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२३.७८ लाख
२४.९९ लाख
१५.७७ लाख
२२.४९ लाख
Operating expense
३८.०७ लाख
२४.९९ लाख
७१.०० लाख
२२.४९ लाख
Total operating expenses
३८.०७ लाख
३६.७४ लाख
२४.९५ लाख
३१.५१ लाख
Operating income
-३८.२८ लाख
-३६.७२ लाख
-१४.७१ लाख
-२९.९९ लाख
Other non operating income
-१.८९ लाख
१.०९ लाख
२९.५५ हजार
-९९१.००
EBT including unusual items
-४०.१६ लाख
-३५.६३ लाख
-१४.४२ लाख
-३०.०० लाख
EBT excluding unusual items
-४०.१६ लाख
-३५.६३ लाख
-१४.४२ लाख
-३०.०० लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-४०.१६ लाख
-३५.६३ लाख
-१४.४२ लाख
-३०.०० लाख
Net profit margin
१८,९७०.७३%
-१,५७,५०५.१३%
-१४०.८४%
-१,९६७.७२%
Earnings per share
-०.४५
-०.२८
-०.१०
-०.२०
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-३३.६८ लाख
-३१.९० लाख
-९.३७ लाख
-२४.४४ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer